Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for REGADENOSON
- Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
- Treat COVID-19 Patients With Regadenoson
- A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
- New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)
- Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System
- The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
- Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
- A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI
- Allograft Dysfunction in Heart Transplant
- Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
- Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements
- Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging
- Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
- Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF
- Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
- Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
- Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
- Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
- Microvascular Disease Exercise Trial
- Stress CT Perfusion in Patients With Chest Pain
- Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies
- Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation
- Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
- Heart Rate Response to Regadenoson and Sudden Cardiac Death
- Phase Analysis and Obstructive CAD on Rubidium PET
- Regadenoson and Adenosine
- A Phase II Trial of Regadenoson in Sickle Cell Anemia
- Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
- Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients
- The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion
- Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
- A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
- Microvascular Blood Flow in Sickle Cell Anemia
- Regadenoson Real Time Perfusion Imaging Trial-Optison
- Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
- Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
- Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers
- Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress
- Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging
- A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
- Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients Undergoing Myocardial Perfusion Imaging
- Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia
- Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography
- Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET
- Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing
- Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging
- Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)
- Stress Echocardiography Study With Regadenoson
- Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson
- Stress Testing and Cardiac Magnetic Resonance
- A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
- A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
- Effects of Body Mass Index on the Hyperemic Response to Regadenoson
- Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
- Regadenoson R-T Perfusion Imaging Trial
- Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
- Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
- ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
- ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
Clinical trials list
click for details